AbCellera Biologics
ISIN CA00288U1066
|WKN A2QKXS
Market cap (in EUR)
553.35 m
Country
Canada
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Healthcare Healthcare Services Miscellaneous Healthcare Canada
Financials
Key metrics
| Market capitalisation, EUR | 553.35 m |
| EPS, EUR | -0.53 |
| P/B ratio | 0.60 |
| P/E ratio | 12.17 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 26.66 m |
| Net income, EUR | -150.56 m |
| Profit margin | -564.83% |
What ETF is AbCellera Biologics in?
There are 5 ETFs which contain AbCellera Biologics. All of these ETFs are listed in the table below. The ETF with the largest weighting of AbCellera Biologics is the Fidelity Global Equity Research Enhanced UCITS ETF ACC-USD.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Fidelity Global Equity Research Enhanced UCITS ETF ACC-USD | 0.12% | Equity World Social/Environmental | 79 |
| iShares Ageing Population UCITS ETF | 0.07% | Equity World Health Care Social/Environmental Ageing Population | 426 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.08% | Equity United States Health Care Biotech | 22 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.08% | Equity United States Health Care Biotech | 360 |
| iShares Healthcare Innovation UCITS ETF | 0.08% | Equity World Health Care Social/Environmental Innovation | 823 |
Savings plan offers
Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
